THE SHARE: Change: -0.01 SEK (-4.44%) / Price: 0.17 SEK / Dec 6, 2024, 6:00 pm (CET)

Home
About
Technology
Portfolio
Investor Relations
Media
Contact
- Contact us

28 Mar, 2024

Interview with CEO Mats Hansen – Redeye

About Spago Nanomedical

Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of life-threatening and debilitating diseases.

Address

Spago Nanomedical AB
Scheelevägen 22
SE-223 63 Lund
Sweden

Contact

Phone: +46 46 811 88
LinkedIn